Established in 1997 with headquarter based in Zhuhai, China, Rundu Pharma is committed to developing, producing and marketing affordable, high quality generic drugs as well as active pharmaceutical ingredients. We boast of the complete supply chain from intermediates to APIs and to finished products, by leveraging which we stand out as a leading pharmaceutical company home and abroad. Our business is focused on delivering to patients and clients innovative products empowered by our modified release technology platform and based on the core therapeutic areas of Cardiovascular, Gastrointestinal and CNS. We are the leading global supplier of a diversity of APIs, the essential active substance for the drug manufacturing industry. Today we produce approximately 800 tons of APIs and intermediates and 1.5 billion capsules and tablets a year. We sell to more than 200 clients in more than 20 countries worldwide. We dedicate to quality in every stage of the development, production and marketing of our products, we continuously invest in state-of-the-art manufacturing facilities and analytical instruments to support our quality team and make sure the quality of our products. Facilities are qualified and processes are validated, our adherence to cGMP and ICH guidelines are recognized by CFDA, PMDA (Japan) and MFDS (Korea) approvals, EDQM and US FDA site inspections are also triggered and expected soon. Our 5000m2 R&D composite building houses more than 120 dedicated R&D scientists and our Post-PhD working station collaborates with renowned universities and academic institutes on a number of products and projects Facing a global market, we strive for timely, reliable and cost-effective distribution because we understand it is critical to our clients when they try to provide their market with products at the right time. Our continuous drive for excellence is expressed in everything we do. We will never compromise our commitment and sense of responsibility to our

Registered Capital:  241.383025 million

Registered Address:  No.6, North Airport Road, Sanzao Town, Jinwan District, Zhuhai, Guangdong, 519041 China

Company Type:  Production

Business Scope:  Research and development, production and sales of apis, small-volume injections, tablets, hard capsules, dry suspension agents, pharmaceutical intermediates (pellets), pharmaceutical excipients, pharmaceutical intermediates (excluding dangerous goods) (for projects subject to approval according to law, business activities can only be carried out after approval by relevant departments)